Kaitlyn D’Onofrio

DocwireNews

A new study assessed complications and risk factors for mortality among a special group of operative <a href="https://www.docwirenews.com/rheumatology/recovery-rate-and-length-of-stay-but-not-therapy-time-affect-discharge-position-following-hip-fracture-surgery/">hip fracture patients</a>: centenarians.
As the population continues living longer, the study authors pointed out that “the population of individuals aged over 100 years in 2016 was 558,597, twice as many as a decade ago, and half as many as the expected population in 2027. Centenarians are characterised by a high comorbidity burden, polypharmacy, and therefore, high surgical risk. According to recent studies, fractures are the third cause of hospitalisation in this age group, after infections and cardiovascular events. Advanced age has been shown to be an independent risk factor for poor prognosis and mortality after hip fracture.”
To explore outcomes in centenarians, the researchers retrospectively analyzed 69 <a href="https://www.docwirenews.com/condition-center/orthopedicscc/orthopedics-center-picks/could-bereavement-affect-frailty-spousal-death-increases-hip-fracture-risk/">hip fracture patients</a> (average age, 101.3 years; 58 centenarians were female) aged 100 years or older admitted to a tertiary hospital between 1999 and 2018.
Extracapsular fractures were recorded in 62.3% of centenarians. Delirium was the most common complication, observed in just over half of patients (52.3%), followed by urinary retention (27.7%); 9.2% of patients sustained hematoma, the most common surgical complication. Following admission, three patients (7.3%) changed their place of residence. The in-hospital mortality rate was 13.8%; the 30-day and one-year mortality rates were 21.5% and 54.2%, respectively. Risk factors for in-hospital mortality among centenarians were a high Charlson Comorbidity Index (odds ratio [OR]=1.95; 95% confidence interval [CI], 1.03 to 3.69) and baseline Functional Ambulation Classification (FAC) &lt;3 (OR=5.7; 95% CI, 1.2 to 26.8). Risk factors for 30-day mortality for centenarians were having more than three comorbidities (OR = 6; 95% CI, 1.4 to 24.7) and baseline FAC &lt;3 (OR=4, 95% CI, 1.13 to 14.2). Dementia was a risk factor for 30-day (OR=4.6; 95% CI, 1.2 to 16.7) and one-year mortality (OR=5.11; 95% CI, 1.6-21.0) among centenarians.
The report was published in <a href="https://www.injuryjournal.com/article/S0020-1383(20)30280-1/fulltext?rss=yes">Injury</a>.
“Because of the special baseline characteristics of centenarians, results from studies on the surgical treatment of HF in younger patients cannot reliably be extrapolated to this group. FAC scores, number of comorbidities, dementia and Charlson Comorbidity Index have been shown to be predictors mortality in our patients. More studies are needed to confirm these results,” the study authors concluded.

Cecilia Brown

Osimertinib Plus Chemotherapy Approved in China as First-Line Treatment for EGFR-Mutated Advanced NSCLC

Non-Small Cell Lung Cancer

Emily Menendez

TACE Plus Sorafenib Boosts OS, PFS in Intermediate Recurrent HCC With Positive MVI

Hepatocellular Carcinoma

Narjust Florez, MD, FASCO

Dr. Narjust Florez on the Psychosocial Needs of Young Patients With Lung Cancer

ASCO 2024: Focus on Lung Cancer

Latest News

Is Age Just A Number? Mortality Risk Factors for Centenarians Undergoing Hip Fracture Surgery

Orthopedics

A new study assessed complications and risk factors for mortality among a special group of operative hip fracture patients: centenarians. ...

About Us

Editorial Policy

Advertising

eNewsletters

Contribute

Contact Us

MashupMD

Blood Cancers Today

Cancer Nursing Today

GU Oncology Now

Urban Health Today

Bile Duct Cancer

Colorectal Cancer

Gastroesophageal Cancer

Gastric Cancer

GEP-NETs

GIST

Liver Cancer

Pancreatic Cancer

GI Oncology Now

Anemia

Deep Vein Thrombosis

Essential Thrombocythemia

Hemophilia

Immune Thrombocytopenic Purpura

Myelodysplastic Syndromes

Myelofibrosis

Myeloproliferative Neoplasms

Polycythemia Vera

Pulmonary Embolism

Sickle Cell Disease

Thrombocytopenia

Thrombophilia

Thrombosis

Thrombotic Thrombocytopenic Purpura

Venous Thromboembolism

von Willebrand Disease

Heme Today

Acute Kidney Injury

ADPKD

Anemia and Kidney Disease

Chronic Kidney Disease

COVID-19 and Kidney Disease

Diabetes and Hypertension

End-Stage Renal Disease

Gout

Hyperkalemia

IgAN

Kidney Transplantation

Metabolic Acidosis

Nephrology Times

Mesothelioma

Small Cell Lung Cancer

Squamous Cell Lung Carcinoma

Lung Cancers Today

Onc Brothers Event

Atherosclerotic Disease

Atrial Fibrillation

Heart Failure

Hypertension

Interventional Cardiology

Lipid Management

Practice Tips With Dr. Lichaa

Preventive Cardiology

Stroke

Cardiology

Diabetes

Oncology

Neurology

Rheumatology

Gastroenterology

Pulmonology

Ophthalmology

Infectious Diseases

— HIV

Health and Wellness

Future of Medicine

Pharmacology

Career News

More

Conferences

CardioNerds

The Sleep Source With Dr. Morse

The Oncology Brothers

Rheumatology Rounds With Dr. Maheswaranathan

Healthcare Unfiltered

The Fellow on Call

Partners

Career Center

Expert Interviews

Subscribe